Testing and Treatment for Syphilis After Potential Exposure
For patients concerned about potential exposure to syphilis, the recommended approach is serological testing with both nontreponemal (VDRL, RPR) and treponemal (FTA-ABS, TP-PA) tests, followed by appropriate treatment based on disease stage if positive. 1
Diagnostic Testing
Initial Testing
- Serological testing is the cornerstone of syphilis diagnosis:
- Nontreponemal tests: RPR or VDRL (should be reported quantitatively)
- Treponemal tests: FTA-ABS or TP-PA (for confirmation)
Testing Algorithm
Traditional approach (recommended by CDC):
Reverse sequence screening (alternative approach):
- Initial screening with treponemal test (EIA/CIA)
- If positive, follow with nontreponemal test
- If discordant results (treponemal positive, nontreponemal negative), perform a second treponemal test 2
Additional Testing
- Direct detection methods for visible lesions:
- Darkfield microscopy or direct fluorescent antibody tests of lesion exudate 1
- CSF examination is indicated for:
- Patients with neurological symptoms
- Evidence of active tertiary syphilis
- HIV co-infection with late latent syphilis 1
Treatment Recommendations
Primary, Secondary, and Early Latent Syphilis (< 1 year duration)
- First-line treatment: Benzathine penicillin G 2.4 million units IM in a single dose 1
- For penicillin-allergic non-pregnant patients:
Late Latent Syphilis or Latent Syphilis of Unknown Duration (> 1 year)
- First-line treatment: Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 1
- For penicillin-allergic non-pregnant patients:
Neurosyphilis
- First-line treatment: Penicillin G aqueous 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1
- For penicillin-allergic patients: Desensitization followed by penicillin treatment (no effective alternatives) 1
Management of Sexual Partners
- Sexual partners exposed within 90 days of diagnosis of primary, secondary, or early latent syphilis should be treated presumptively, even if seronegative 4, 1
- Sexual partners exposed >90 days before diagnosis should be treated presumptively if serologic test results are not immediately available and follow-up is uncertain 4
- For partners of patients with latent syphilis of unknown duration with high nontreponemal titers (≥1:32), treat as early syphilis 4
- Long-term partners of patients with late latent syphilis should be evaluated clinically and serologically and treated based on findings 4, 1
Follow-up and Monitoring
- Quantitative nontreponemal tests should be performed at:
- 6,12, and 24 months after treatment 1
- Criteria for treatment success:
- Retreatment considerations:
- Four-fold increase in titer
- Failure of initially high titer (≥1:32) to decrease four-fold within appropriate timeframe
- Persistence or recurrence of symptoms 1
Special Considerations
- All patients with syphilis should be tested for HIV due to high co-infection rates 4, 1
- Pregnant patients with penicillin allergy should undergo desensitization followed by penicillin treatment 1
- HIV-infected patients may require more careful follow-up due to potentially higher rates of neurological complications and treatment failure 1
Common Pitfalls to Avoid
- Relying solely on one type of serologic test - Both nontreponemal and treponemal tests are needed for accurate diagnosis
- Missing neurosyphilis - Consider CSF examination in patients with neurological symptoms
- Inadequate follow-up - Ensure proper serological monitoring after treatment
- Failure to test and treat partners - Critical for preventing reinfection and further transmission
- Not testing for HIV - Syphilis and HIV co-infection is common
Remember that early detection and appropriate treatment are essential for preventing progression to later stages of disease and reducing transmission to others.